Sponsor Pipeline

Yayi He Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07538258 Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small… Limited-stage Small Cell Lung Cancer (LS-SCLC) Not Yet Recruiting
NCT07538271 A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People… SCLC, Extensive Stage Not Yet Recruiting
NCT07632209 Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small… SCLC, Extensive Stage Not Yet Recruiting
Disease Areas
Get alerts when Yayi He's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free